DOJ Drops DaVita Inquiry

Comments
Loading...
DENVER--(BUSINESS WIRE)-- DaVita Inc. DVA announced that the United States Attorney's Office (USAO) for St. Louis recently informed the company that the USAO completed its investigation and is not taking any action against the company. In March 2005, the St. Louis USAO initiated its inquiry with a subpoena and subsequent document requests in connection with a joint civil and criminal investigation. The broad requests covered a range of topics including financial relationships with physicians and joint ventures. They also covered other services provided to patients, including the administration and billing of Epogen®. DaVita® fully cooperated with the government investigation, providing hundreds of thousands of documents. The USAO closed its investigation without filing any charges, without See full press release
DVA Logo
DVADaVita Inc
$141.12-1.06%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum46.11
Growth67.03
Quality77.49
Value40.19
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Posted In: